Biodesix/$BDSX
1D1W1MYTD1Y5YMAX
Capital at risk
About Biodesix
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
- Ticker
- $BDSX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 334
- Headquarters
- Louisville, United States
- Website
- www.biodesix.com
Biodesix Metrics
BasicAdvanced
$297M
-
-$3.13
0.56
-
Price and volume
Market cap
$297M
Beta
0.56
52-week high
$31.31
52-week low
$5.26
Average daily volume
109K
Financial strength
Current ratio
2.849
Quick ratio
2.558
Long term debt to equity
7.676
Total debt to equity
7.852
Interest coverage (TTM)
-2.54%
Profitability
EBITDA (TTM)
-15.005
Gross margin (TTM)
82.50%
Net profit margin (TTM)
-26.97%
Operating margin (TTM)
-19.99%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
-14.05%
Return on equity (TTM)
-540.01%
Valuation
Price to revenue (TTM)
2.429
Price to book
32.48
Price to tangible book (TTM)
-33.5
Price to free cash flow (TTM)
-12.256
Free cash flow yield (TTM)
-8.16%
Free cash flow per share (TTM)
-2.297
Growth
Revenue change (TTM)
34.46%
Earnings per share change (TTM)
-44.27%
3-year revenue growth (CAGR)
35.21%
3-year earnings per share growth (CAGR)
-46.83%
Upcoming events
No upcoming events
Biodesix News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.